Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Orchard Therapeutics plc (ORTX)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 38.3 | 61.5 | 68.4 | 80.8 | 53.5 | 60.8 | 55.9 | 74.3 |
| Short-term investments | | | | | | 138.2 | | 179.8 |
| Accounts receivable, net | 9.5 | | 8.5 | 4.2 | 4.1 | 4.1 | 1.5 | 1.1 |
| Other current assets | 133.5 | 104.7 | 91.3 | 94.3 | 147.7 | 34.3 | 217.9 | 36.2 |
| Total current assets | 181.3 | 166.2 | 168.1 | 179.3 | 205.3 | 237.4 | 275.3 | 291.5 |
| Property, plant, and equipment, net | 7.8 | 8.1 | 8.1 | 7.8 | 5.7 | 4.5 | 4.8 | 4.8 |
| Intangibles | 3.5 | 3.5 | 3.6 | 3.5 | 3.7 | 4.0 | 4.1 | 4.7 |
| Other fixed assets | 12.4 | 12.3 | 12.1 | 11.8 | 10.7 | 10.7 | 9.6 | 12.2 |
| Total assets | 232.3 | 217.0 | 218.9 | 234.1 | 259.2 | 291.5 | 322.4 | 355.7 |
| |
| Accounts payable | 7.0 | 8.8 | 9.3 | 6.5 | 8.8 | 9.9 | 10.0 | 6.1 |
| Accrued expenses | 11.7 | 9.4 | 14.6 | 10.1 | 7.1 | 26.0 | 9.4 | 28.5 |
| Short-term debt | 9.4 | 9.4 | 9.4 | 7.9 | 5.5 | 3.1 | 0.8 | 0.0 |
| Short-term debt | 9.4 | 9.4 | 9.4 | 7.9 | 5.5 | 3.1 | 0.8 | |
| Deferred revenues | 0.8 | 0.6 | 1.0 | 1.4 | 1.1 | 0.9 | 0.3 | 1.4 |
| Other current liabilities | 28.7 | 25.0 | 26.3 | 24.4 | 25.9 | 7.0 | 22.3 | 8.3 |
| Total current liabilities | 57.5 | 53.3 | 60.6 | 50.3 | 48.4 | 46.9 | 42.8 | 44.2 |
| Long-term debt | 18.4 | 20.7 | 23.0 | 25.3 | 27.5 | 29.8 | 32.1 | 32.8 |
| Other liabilities | 47.3 | 41.4 | 37.1 | 34.8 | 36.9 | 39.1 | 37.6 | 37.3 |
| Total liabilities | 123.3 | 115.4 | 120.6 | 110.3 | 112.9 | 115.9 | 112.5 | 114.4 |
| |
| Shareholders' equity [+] | 109.0 | 101.7 | 98.3 | 123.7 | 146.3 | 175.6 | 210.0 | 241.3 |
| Paid-in capital | 991.6 | 975.7 | 956.7 | 952.8 | 949.3 | 945.3 | 940.7 | 935.2 |
| Retained earnings | -930.6 | -918.3 | -900.9 | -893.0 | -845.4 | -794.5 | -750.2 | -713.9 |
| Tangible shareholders' equity | 105.6 | 98.1 | 94.7 | 120.2 | 142.5 | 171.7 | 205.8 | 236.6 |
|